Qiagen N.V.
QGEN
주식 순위
#2056
Qiagen N.V. provides sample to insight solutions that transform biological... Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
주가
$48.85
시가총액
$10.07B
변동 (1일)
4.96%
변동 (1년)
0.36%
국가
NL
거래 Qiagen N.V. (QGEN)
카테고리
Healthcare
Qiagen N.V. (QGEN)의 발행 주식 수
June 2026 기준 발행 주식 수: 206.35M
Qiagen N.V.의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 206.35M입니다. December 2024 말 기준 회사는 216.44M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Qiagen N.V. (QGEN)의 발행 주식 수 기록 (2000 ~ 2026)
매년 말 기준 발행 주식 수
| 연도 | 발행 주식 수 | 변화 |
|---|---|---|
| 2026 (TTM) | 206.35M | -0.77% |
| 2025 | 207.94M | -3.93% |
| 2024 | 216.44M | -0.48% |
| 2023 | 217.49M | -1.48% |
| 2022 | 220.75M | -0.18% |
| 2021 | 221.14M | -0.19% |
| 2020 | 221.57M | 0.73% |
| 2019 | 219.97M | -2.45% |
| 2018 | 225.51M | -1.12% |
| 2017 | 228.07M | 0.97% |
| 2016 | 225.87M | 0.67% |
| 2015 | 224.38M | 0.42% |
| 2014 | 223.43M | -0.80% |
| 2013 | 225.23M | -0.28% |
| 2012 | 225.86M | 0.14% |
| 2011 | 225.55M | 0.47% |
| 2010 | 224.48M | 12.65% |
| 2009 | 199.26M | 5.14% |
| 2008 | 189.51M | 16.83% |
| 2007 | 162.22M | 12.68% |
| 2006 | 143.97M | 1.13% |
| 2005 | 142.36M | 0.80% |
| 2004 | 141.23M | 0.57% |
| 2003 | 140.43M | 0.72% |
| 2002 | 139.43M | 1.28% |
| 2001 | 137.67M | 0.65% |
| 2000 | 136.78M | 0.00% |
유사 기업 또는 경쟁사의 발행 주식 수
| 회사 | 발행 주식 수 | 차이 | 국가 |
|---|---|---|---|
| 371.00M | 79.80% |
US
|
|
| 705.30M | 241.80% |
US
|
|
| 143.28M | -30.56% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 36.66% |
US
|
